We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
These draft regulations set out the additional conditions that expenditure by employers on recommended medical treatment must meet in order to qualify for the tax exemption at section 12 of Finance Act 2014.
How to use a cost benefit analysis to evaluate your digital health product.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Wet line contamination involves the cross contamination of road fuel with rebated fuels, which will either be red diesel or kerosene.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Rules for UK and EU broadcasters and video on-demand services
Annual recommendations by the Prescribed Specialised Services Advisory Group (PSSAG) to ministers on services that NHS England should commission.
Information to help you identify if your organisation needs to publish a modern slavery statement.
Share your reference data for use in projects and services outside your organisation.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
This document explains the NHS view on private screening for different conditions and diseases.
This guidance summarises the types of defects to which the leaseholder protections in the Building Safety Act 2022 apply.
How to use a before-and-after study to evaluate your digital health product.
How the Industrial Emissions Best Available Technique (BAT) regime works from the end of the transition period.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
Recommendations for a temporary class drug order on a number of methylphenidate-based novel psychoactive substances.
What best available techniques are, when you must follow them, how to propose alternatives and how to refer to them in your application.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).